In 2017, Cardiovascular Diseases, Heart
In 2017, Cardiovascular Diseases, Heart
Isang malawak na pagpipilian ng mga gamot mismo pati na rin ng mga pamamaraan para sa pagbawas ng gamot mula sa mataas na presyon ang nagbibigay-daan sa iyo na pumili ng pinaka-komportableng programa ng paggamot – ang abot-kaya sa gastos, na may minimal na pagpapakita ng mga side effect, at isinasaalang-alang ang ibang kasamang sakit. Kapag matagal ang pag-inom ng tabletas at binabago ng doktor ang gamot, ito ay dahil ang ilang gamot ay may katangian na magdulot ng pagkagumon, na nagreresulta sa kaunting pagbaba ng bisa nito. Bukod dito, hindi lahat ng grupo ng gamot ay angkop para sa mga pasyente sa iba't ibang edad, at may mga limitasyon din sa pagiging compatible nito sa ibang uri ng gamot.
ЧИТАТЬ ДАЛЕЕ ...
Cardiovascular disease and heart health: the state of the research in the year 2017 In 2017, cardiovascular diseases (KVE) remained the leading cause of death worldwide and in Germany. According to statistics from the Robert Koch Institute and the German heart Foundation KVE accounted for about 30% of all deaths, heart attacks, heart failure and stroke were the most common clinical manifestations. Epidemiological Trends The epidemiological data from 2017 showed a slight decrease in the incidence of acute heart attacks in persons over 65 years, which was due to the improvement of preventative measures and drug therapy. At the same time an increase in the number of heart failure cases, however, was observed in younger patients (under 55 years), and in particular in individuals with obesity, type 2 Diabetes mellitus and arterial hypertension. Risk factors Of the modifiable risk factors included in the year 2017: arterial hypertension (blood pressure≥140/90 mmHg), Hyperlipidemia (elevated levels of LDL‑cholesterol >3.0 mmol/l), Tobacco, physical inactivity, unhealthy diet, Obesity (BMI ≥30 kg/m 2 ), Diabetes mellitus. Non-modifiable risk factors included age, gender (male), and family history of early cardiovascular events. Diagnostic Progress In 2017, have been published new guidelines for the diagnosis of heart illnesses, especially on the following methods: ECG for the detection of arrhythmias and Ischemia, Echocardiography for the assessment of cardiac function and valve defects, Coronary computed tomography (CCTA) as a non‑invasive Alternative to conventional coronary angiography, Biomarkers such as high-sensitive Troponin and NT‑proBNP for the early detection of myocardial damage and heart failure. Therapeutic Approaches The treatment strategies in 2017 included: Drug Therapy: ACE inhibitor or ARB in heart failure, Beta-blockers to reduce heart rate and blood pressure monitoring, Statins for lipid-lowering, Anticoagulants (aspirin, Clopidogrel) after myocardial infarction. Interventional Procedures: Percutaneous coronary Intervention (PCI) with stent implantation, Ablation therapy for atrial fibrillation. Prevention: Regular physical activity (150 minutes/week of moderate stress), Change in diet (DASH diet, Mediterranean diet), Smoking abstinence Blood pressure and blood sugar control. Conclusion The year 2017 marked an important step in the development of prevention and treatment strategies for circuit-limiting diseases. The Integration of new diagnostic methods and evidence-based therapy concepts improved the prognosis of patients with cardiovascular diseases significantly. Nevertheless, the control of risk factors and the promotion of a healthy life style, a Central challenge for the future.
A sedentary lifestyle, alcohol, and cigarette consumption increase body weight which in turn hinders healthy blood circulation and strength of arteries and veins. This results in high blood pressure. So, if you’re overweight, you need to monitor your blood pressure frequently. In 2017, Cardiovascular Diseases, Heart. Ang Cardio Balance Kapseln ay isang epektibo at ligtas na paraan para mapanatili ang kalusugan ng puso at pababain ang presyon ng dugo. Dahil sa kanilang natural na sangkap at mataas na bisa, nagiging maaasahang katuwang sila sa paglaban sa mataas na presyon ng dugo at sa pagpapabuti ng kalidad ng buhay.
Atherosclerotic Cardiovascular Diseases
The main reason for death among cardiovascular diseases
Medicines for high blood pressure price
http://bux.webtm.ru/posts/96381-disease-of-the-circulatory-system-of-the-people.html
http://p929313j.beget.tech/posts/68742-what-high-blood-pressure-causes.html
Una sa lahat, ang mga Beta-blocker ay karaniwang ibinibigay sa mga pasyente na may heart failure, aortic aneurysm, pagkatapos ng myocardial infarction, at sa mga kababaihan na nasa edad ng pagbubuntis, lalo na sa mga kababaihang nagpaplano ng pagbubuntis. Madalas matanggap ng katawan ang Beta-blocker, pero maaari rin itong magdulot ng pantal sa balat at bradycardia – sobrang bagal ng tibok ng puso. Diuretiko (Diuretika) ay nagpapataas ng pag-ihi ng katawan, na nagreresulta sa pagbaba ng presyon ng dugo. Simpleng paliwanag: Ang tuloy-tuloy na pag-ihi ng katawan ay nagdudulot ng pagbaba ng dami ng plasma sa dugo at sa gayon ay mas kaunting likido sa mga ugat — bumababa ang presyon sa mga pader ng ugat.
Cardiovascular diseases and their coding in the ICD‑10 Cardiovascular disease (HKL diseases) represent an important group of diseases that affect the heart and the blood circulatory system. For the uniform collection and classification of these disorders and the International statistical classification of diseases and related health problems (ICD), in its tenth Revision, known as ICD‑10 is used. The Chapter IX of the ICD‑10 Codes I00 to I99 includes the diseases of the circulatory system. This Chapter is used in epidemiology and statistics as the basis for the Definition of cardiovascular disease. Overview of the main code groups in the area of I00–I99: I00–I02 Acute rheumatic fever; I05–I09 Chronic rheumatic heart disease (e.g., rheumatic mitral valve stenosis); I10–I15: High Blood Pressure (Hypertension); I20–I25: Ischemic heart disease (including coronary heart disease and heart attack); I26–I28: Pulmonary heart disease and diseases of pulmonary circulation (e.g., pulmonary hypertension); I30–I52 Other forms of heart disease (such as pericarditis, myocarditis, heart rhythm disturbances); I60–I69: Cerebrovascular diseases (e.g. cerebral haemorrhage and cerebral infarction); I70–I-79: diseases of arteries, arterioles and capillaries (including atherosclerosis); I80–I89 diseases of veins, blood vessels, lymph, and lymph nodes; I95–I99 Other and unspecified diseases of the circulatory system (e.g., hypotension). Remarks on the distinction Not in this classification are included: congenital heart defects (they will be encoded in Chapter XVII, Q00–Q99,); Tumors of the heart or the vessels of (a part of neoplasms, Chapter II C00–D48); acute injuries of the heart and blood vessels; some inflammatory vascular diseases such as Polyarteritis nodosa or Takayasu's syndrome. Meaning of the ICD‑10 coding The standardized coding to ICD‑10 allows you to: comparable statistical detection of HVAC diseases at national and international level; Planning and Evaluation of prevention and treatment measures; Billing of services in the health sector; scientific studies and epidemiology (e.g., WHO studies how the MONICA study). The exact assignment of a disease to an ICD‑10 Code is, therefore, in the medical documentation, the health reporting and health care research is of Central importance. You want me to treat a particular aspect of this topic in greater detail or further examples of additional?